Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$117.13 - $176.59 $258,740 - $390,087
-2,209 Closed
0 $0
Q1 2022

Feb 08, 2024

BUY
$126.46 - $235.05 $170,721 - $317,317
1,350 New
1,350 $232,000
Q4 2021

Feb 17, 2022

SELL
$225.82 - $368.51 $257,660 - $420,469
-1,141 Reduced 34.06%
2,209 $561,000
Q3 2021

Dec 03, 2021

BUY
$221.9 - $484.47 $205,701 - $449,103
927 Added 38.26%
3,350 $1.29 Million
Q2 2021

Aug 17, 2021

SELL
$129.91 - $234.98 $12,861 - $23,263
-99 Reduced 3.93%
2,423 $570,000
Q1 2021

May 24, 2021

BUY
$109.18 - $185.98 $275,351 - $469,041
2,522 New
2,522 $334,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.